Fox Run Management’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$445K Sell
42,989
-56,416
-57% -$705K 0.08% 489
2025
Q4
$1.29M Buy
99,405
+52,587
+112% +$675K 0.2% 120
2025
Q3
$605K Buy
46,818
+26,530
+131% +$354K 0.09% 414
2025
Q2
$361K Buy
+20,288
New +$354K 0.06% 588
2024
Q4
Sell
-32,451
Closed -$507K 1081
2024
Q3
$507K Buy
+32,451
New +$588K 0.11% 351
2024
Q2
Sell
-15,809
Closed -$247K 980
2024
Q1
$247K Sell
15,809
-10,415
-40% -$153K 0.05% 580
2023
Q4
$392K Buy
26,224
+6,840
+35% +$91.5K 0.1% 392
2023
Q3
$313K Buy
+19,384
New +$559K 0.09% 428
2018
Q2
Sell
-10,597
Closed -$231K 837
2018
Q1
$231K Buy
+10,597
New +$228K 0.06% 584
2017
Q4
Sell
-23,200
Closed -$461K 813
2017
Q3
$461K Buy
23,200
+10,200
+78% +$200K 0.13% 321
2017
Q2
$225K Buy
+13,000
New +$168K 0.08% 510

Other funds holding NVCR